| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |